Boston Scientific Stock News

We think that Boston Scientific stock currently is a better pick compared to its industry peer, Medtronic stock, despite it being the more expensive of the two, trading at 5.3x trailing revenues compa

Abbott (ABT), Boston Scientific (BSX) and Medtronic (MDT) are the most likely potential buyers of ShockWave Medical (SWAV) after a report late Friday that the company has received…

MARLBOROUGH, Mass. , Jan. 7, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at the 25th North American Neuromodulation Society (NANS) ann

The U.S. Securities and Exchange Commission has closed an investigation into whether Boston Scientific violated federal securities laws in connection with its decision last year to stop selling its Lotus Edge heart device.

MARLBOROUGH, Mass., Jan. 4, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 40th Annual J.P.

We report the most recent holdings and the trading signals for 12/27/2021. Click here to read this week's trading update of Outperforming The S&P 500.

Boston Scientific Co. (NYSE:BSX) EVP David A. Pierce sold 49,988 shares of the businesss stock in a transaction on Monday, December 20th. The shares were sold at an average price of $39.90, for a total value of $1,994,521.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available [] The post Insider Selling: Boston Scientific Co. (NYSE:BSX) EVP Sells 49,988 Shares of Stock appeared first on ETF Daily News .

Boston Scientific (NYSE:BSX) had its price objective upped by Truist Securities from $52.00 to $53.00 in a report released on Tuesday, Price Targets.com reports. Truist Securities currently has a buy rating on the medical equipment providers stock. A number of other brokerages also recently weighed in on BSX. Raymond James lowered their target price on []

In recent trading session, Boston Scientific Corporation (NYSE:BSX) saw 1.62 million shares changing hands at last check today with its beta currently measuring 0.87. Companys recent per share price level of $42.87 trading at $0.71 or 1.68% at last check today assigns it a market valuation of $59.45B. That most recent trading price of BSXs Boston Scientific Corporation (NYSE:BSX) At $42.87: So What? Read More »

DUBLIN--(BUSINESS WIRE)--The "Global Interventional Oncology Market 2021-2026" report has been added to ResearchAndMarkets.com''s offering. The global interventional oncology market should reach $3.1 billion by 2026 from $2.2 billion in 2021 at a compound annual growth rate (CAGR) of 7.0% for the forecast period of 2021 to 2026. The embolization devices segment of the global interventional oncology market is expected to grow from $1.3 billion in 2021 to $1.9 billion in 2026 at a CAGR of 7.7% for

Stocks like Boston Scientific (BSX), Medtronic (MDT), DexCom (DXCM) and Syneos Health (SYNH) are evolving rapidly in the field of IoMT.

The research reports on Flexible Video Ureteroscope (URF-V) Market report gives detailed overview of factors that affect global business scope. Flexible Video Ureteroscope (URF-V) Market report shows the latest market insights with upcoming trends and breakdowns of products and services.

Los Angeles, United State, ,- This research study is one of the most detailed and accurate ones that solely focus on the global Gastrointestinal Bleeding Treatment market. It sheds light on critical factors that impact the growth of the global

Los Angeles, United State, ,- This research study is one of the most detailed and accurate ones that solely focus on the global Uterine Fibroids Treatment market. It sheds light on critical factors that impact the growth of the global